Seres Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 38,091 | 0.0252% |
Individual Insiders | 1,245,201 | 0.825% |
Public Companies | 7,496,038 | 4.96% |
VC/PE Firms | 23,117,045 | 15.3% |
General Public | 52,935,503 | 35.1% |
Institutions | 66,177,584 | 43.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
23,117,045 | US$14.7m | 0% | 1.02% | |||
19,388,580 | US$12.3m | 0.82% | no data | |||
7,496,038 | US$4.8m | 0% | no data | |||
6,825,399 | US$4.3m | -7% | no data | |||
6,005,307 | US$3.8m | 9.65% | no data | |||
4,320,400 | US$2.7m | 116% | 0.03% | |||
2,359,649 | US$1.5m | 88.6% | no data | |||
2,224,075 | US$1.4m | 182% | no data | |||
2,191,860 | US$1.4m | -20.3% | no data | |||
2,094,039 | US$1.3m | 5.36% | no data | |||
1,909,524 | US$1.2m | -80% | no data | |||
1,792,888 | US$1.1m | 0% | 0.12% | |||
1,753,538 | US$1.1m | -25.5% | 0.1% | |||
1,411,050 | US$897.6k | 465% | no data | |||
1,290,276 | US$820.7k | 545% | 0.01% | |||
1,100,000 | US$699.7k | 10% | no data | |||
857,952 | US$545.7k | 155% | no data | |||
817,000 | US$519.7k | 0% | no data | |||
770,611 | US$490.2k | -16.5% | no data | |||
676,387 | US$430.2k | 0% | no data | |||
640,655 | US$407.5k | 287% | no data | |||
402,506 | US$256.0k | 168% | 0.06% | |||
401,098 | US$255.1k | -28.6% | no data | |||
399,501 | US$254.1k | 0% | no data | |||
393,760 | US$250.5k | 0% | no data |